Evaluation of published reports of foam sclerotherapy: What do we know conclusively?

Phlebology

Volumn 24, Issue 6, 2009, Pages 275-280

  Myers, K A ^a   Roberts, S ^a  

^a Victoria Vein Clinic   (Australia)

Author keywords

Foam sclerotherapy; Reticular; Telangiectases; Varicose; Veins

Indexed keywords

CARBON DIOXIDE; POLIDOCANOL; TETRADECYL SULFATE SODIUM;

AIR; AIR EMBOLISM; ANAPHYLAXIS; ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; DEEP VEIN THROMBOSIS; ECCHYMOSIS; ECHOGRAPHY; ENDOVASCULAR SURGERY; FOAM; HEADACHE; HUMAN; INFLAMMATION; INJECTION SITE; LASER SURGERY; LIQUID; OUTCOME ASSESSMENT; PATENT FORAMEN OVALE; PIGMENT DISORDER; PRIORITY JOURNAL; SAPHENOUS VEIN; SCLEROTHERAPY; TELANGIECTASIA; THROMBOEMBOLISM; THROMBOPHLEBITIS; TRANSIENT ISCHEMIC ATTACK; VARICOSIS; VISUAL DISORDER;

CATHETER ABLATION; CLINICAL TRIALS AS TOPIC; DOSAGE FORMS; EMBOLISM, AIR; EVIDENCE-BASED MEDICINE; GASES; HEART DISEASES; HUMANS; INTRACRANIAL EMBOLISM; ISCHEMIC ATTACK, TRANSIENT; LASER THERAPY; META-ANALYSIS AS TOPIC; PROSPECTIVE STUDIES; RECURRENCE; SCLEROSING SOLUTIONS; SCLEROTHERAPY; THROMBOSIS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL; VARICOSE VEINS;

EID: 72149126837     PISSN: 02683555     EISSN: 14333031     Source Type: Journal    
DOI: 10.1258/phleb.2009.009048     Document Type: Article

References (46)

1. Winterborn RJ, Corbett CR. Treatment of varicose veins: the present and the future - a questionnaire survey. Ann Roy Coll Surg Engl 2008;90:561-564
2. Tessari L, Cavezzi A, Frullini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg 2001;27:58-60 (Pubitemid 32107620)
3. Breu FX, Guggenbichler S, Wollmann JC. 2nd European Consensus Meeting on Foam Sclerotherapy 2006, Tegernsee, Germany. Vasa 2008;37(Suppl. 71):1-29
4. Rigby KA, Palfryman SSJ, Beverley C, Michaels JA. Surgery versus sclerotherapy for the treatment of varicose veins (Review). Cochrane Database Syst Rev 2004;10:CD004980
5. Tisi PV, Beverley C, Rees A. Injection sclerotherapy for varicose veins. Cochrane Database Syst Rev 2006;18:CD001732
6. Redondo P, Cabrera J. Microfoam sclerotherapy. Semin Cutan Med Surg 2005;24:175-183
7. Cabrera J. UK Patent Application No. 0422307.9, filed 7 October 2004
8. Parsi K, Exner T, Connor DE, et al. The lytic effects of detergent sclerosants on erythrocytes, platelets, endothelial cells and microparticles are attenuated by albumin and other plasma components in vitro. Eur J Vasc Endovasc Surg 2008;36:216-223 (Pubitemid 351952328)
9. Parsi K, Exner T, Connor DE, et al. In vitro effects of detergent sclerosants on coagulation, platelets and microparticles. Eur J Vasc Endovasc Surg 2007;34:731-740
10. Orsini C, Brotto M. Immediate pathologic effects on the vein wall of foam sclerotherapy. Dermatol Surg 2007;33:1250-1254 (Pubitemid 47508677)
11. Alòs J, Carreño P, López JA, et al. Efficacy and safety of sclerotherapy using polidocanol foam: a controlled clinical trial. Eur J Vasc Endovasc Surg 2006;31:101-107
12. Rabe E, Otto J, Schliephake D, Pannier F. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial. Eur J Vasc Endovasc Surg 2008;35:238-245 (Pubitemid 351163086)
13. Ouvry P, Allaert FA, Desnos P, Hamel-Desnos C. Efficacy of polidocanol foam versus liquid in sclerotherapy of the great saphenous vein: a multicentre randomised controlled trial with a 2-year follow-up. Eur J Vasc Endovasc Surg 2008;36:366-370
14. Yamaki T, Nozaki M, Sakurai H, et al. Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations. J Vasc Surg 2008;47:578-584 (Pubitemid 351258277)
15. Rao J, Wildemore JK, Goldman MP. Double-blind prospective comparative trial between foamed and liquid polidocanol and sodium tetradecyl sulfate in the treatment of varicose and telangiectatic leg veins. Dermatol Surg 2005;31:631-635 (Pubitemid 43093412)
16. Rabe E, Schliephake D, Otto J. Polidocanal, sodium tetradecyl sulphate and placebo for sclerotherapy of C1-varicose veins: a double-blind, randomised, controlled clinical trial (EASI-study). Phlebology 2009;24:86
17. Ceulen RP, Bullens-Goessens YI, Pi-Van De Venne SJ, et al. Outcomes and side effects of duplex-guided sclerotherapy in the treatment of great saphenous veins with 1% versus 3% polidocanol foam: results of a randomized controlled trial with 1-year follow-up. Dermatol Surg 2007;33:276-281
18. Hamel-Desnos C, Ouvry P, Benigni JP, et al. Comparison of 1% and 3% polidocanol foam in ultrasound guided sclerotherapy of the great saphenous vein: a randomised, double-blind trial with 2 year-follow-up. 'The 3/1 Study'. Eur J Vasc Endovasc Surg 2007;34:723-729
19. Myers KA, Jolley D, Clough A, Kirwan J. Outcome of ultrasound-guided sclerotherapy for varicose veins: medium-term results assessed by ultrasound surveillance. Eur J Vasc Endovasc Surg 2007;33:116-121 (Pubitemid 44872674)
20. Tessari L, Cavezzi A, Ross M, Cabrera Garrido A. Variables in foam sclerotherapy: literature and experimental data. Aust NZ J Phlebology 2008;11:83-84
21. Shirazi AR, Goldman M. The use of a 5-microm filter hub increases foam stability when using the double-syringe technique. Dermatol Surg 2008;34:91-92 (Pubitemid 350308594)
22. Lai SW, Goldman MP. Does the relative silicone content of different syringes affect the stability of foam in sclerotherapy? J Drugs Dermatol 2008;7:399-400
23. Hill D. Comparison of foam stability by foam composition. Phlebology 2009;24:86
24. Kern P, Ramelet AA, Wütschert R, Hayoz D. Compression after sclerotherapy for telangiectasias and reticular leg veins: a randomized controlled study. J Vasc Surg 2007;45:1212-1216 (Pubitemid 46817846)
25. Smith PC. Chronic venous disease treated by ultrasound guided foam sclerotherapy. Eur J Vasc Endovasc Surg 2006;32:577-583
26. Pascarella L, Bergan JJ, Mekenas LV. Severe chronic venous insufficiency treated by foamed sclerosant. Ann Vasc Surg 2006;20:83-91 (Pubitemid 43029863)
27. van den Bos R, Arends L, Kockaert M, et al. Endovenous therapies of lower extremity varicosities: a meta-analysis. J Vasc Surg 2009;49:230-239
28. Luebke T, Brunkwall J. Systematic review and meta-analysis of endovenous radiofrequency obliteration, endovenous laser therapy, and foam sclerotherapy for primary varicosis. J Cardiovasc Surg 2008;49:213-233 (Pubitemid 351833242)
29. Abela R, Liamis A, Prionidis I, et al. Reverse foam sclerotherapy of the great saphenous vein with saphenofemoral ligation compared to standard and invagination stripping: a prospective clinical series. Eur J Vasc Endovasc Surg 2008;36:485-490
30. Bountouroglou DG, Azzam M, Kakkos SK, et al. Ultrasound-guided foam sclerotherapy combined with sapheno-femoral ligation compared to surgical treatment of varicose veins: early results of a randomised controlled trial. Eur J Vasc Endovasc Surg 2006;31:93-100 (Pubitemid 43024990)
31. Belcaro G, Cesarone MR, Di Renzo A, et al. Foam-sclerotherapy, surgery, sclerotherapy, and combined treatment for varicose veins: a 10-year, prospective, randomized, controlled, trial (VEDICO trial). Angiology 2003;54:307-315 (Pubitemid 36578462)
32. Gonzalez-Zeh R, Armisen R, Barahona S. Endovenous laser and echo-guided foam ablation in great saphenous vein reflux: one-year follow-up results. J Vasc Surg 2008;48:940-946
33. Theivacumar NS, Dellagrammaticas D, Mavor AI, Gough MJ. Endovenous laser ablation: does standard above-knee great saphenous vein ablation provide optimumresults in patients with both above- and below-knee reflux? A randomized controlled trial. J Vasc Surg 2008;48:173-178
34. Gillet JL, Guedes JM, Guex JJ, et al. Side-effects and complications of foam sclerotherapy of the great and small saphenous veins: a controlled multicentre prospective study including 1025 patients. Phlebology 2009;24:86
35. Jia X, Mowatt G, Burr JM, et al. Systematic review of foam sclerotherapy for varicose veins. Br J Surg 2007; 94:925-936 (Pubitemid 47236534)
36. Myers KA, Jolley D. Factors affecting the risk of deep venous occlusion after ultrasound-guided sclerotherapy for varicose veins. Eur J Vasc Endovasc Surg 2008;36:602-605
37. Gillet JL, Guedes JM, Guex JJ, et al. Side-effects and complications of foam sclerotherapy of the great and small saphenous veins: a controlled multicentre prospective study including 1025 patients. Phlebology 2009;24:86
38. Forlee MV, Grouden M, Moore DJ, Shanik G. Stroke after varicose vein foam injection sclerotherapy. J Vasc Surg 2006;43:162-164 (Pubitemid 43083525)
39. Ceulen RP, Sommer A, Vernooy K. Microembolism during foam sclerotherapy of varicose veins. N Engl J Med 2008;358:1525-1526
40. Rush JE, Wright DD. More on microembolism and foam sclerotherapy. N Engl J Med 2008;359:656
41. Gibson KD, Regon JD, Shortell C, et al. Proprietory polidocanal endovenous microfoam bubble embolization does not cause cerebral injury. Phlebology 2009;24:85
42. Neuhardt D, Morrison N, Rogers C, Salles-Cunha S. Emboli detection in the middle cerebral artery concurrent with treatment of lower extremity superficial venous insufficiency with foam sclerotherapy. Phlebology 2009;24:88
43. Hill D, Hamilton R, Fung T. Assessment of techniques to reduce sclerosant foam migration during ultrasound-guided sclerotherapy of the great saphenous vein. J Vasc Surg 2008;48:934-939
44. Yamaki T, Nozaki M, Sakurai H, Takeuchi M, Soejima K, Kono T. Multiple small-dose injections can reduce the passage of sclerosant foam into deep veins during foam sclerotherapy for varicose veins. Eur J Vasc Endovasc Surg 2009;37:343-348
45. Morrison N, Neuhardt DL, Rogers CR, et al. Comparisons of side effects using air and carbon dioxide foam for endovenous chemical ablation. J Vasc Surg 2008;47:830-836
46. Morrison N, Neuhardt D, Rogers C, et al. Studies on foam migration. Phlebology 2009;24:88